Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use NEXVIAZYME® safely and effectively. See full prescribing information for NEXVIAZYME. NEXVIAZYME (avalglucosidase alfa-ngpt) for injection, for intravenous use Initial U.S. Approval: 2021
Medication labelWhy this: Advisory · dailymed-prescription
NEXVIAZYME is indicated for the treatment of patients 1 year of age and older with late-onset Pompe disease (lysosomal acid alpha-glucosidase [GAA] deficiency).
- generic_name
- avalglucosidase alfa-ngpt
- product_names
- avalglucosidase alfa-ngpt
- ndc
- 58468-0426, 58468-0426-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en